Clinical Trial Update: GSK962040 Drug-drug Interaction Study With Ketoconazole [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study evaluating GSK962040 with ketoconazole for gastroparesis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• GSK962040
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastroparesis | Phase 1 | Status: COMPLETED